NCT05830539 2025-05-02
IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients
InxMed (Shanghai) Co., Ltd.
Phase 1/2 Completed
InxMed (Shanghai) Co., Ltd.
Bio-Thera Solutions
CStone Pharmaceuticals
Genexine, Inc.
Merck Sharp & Dohme LLC